4.5 Article

Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis

Journal

JOURNAL OF NEURO-ONCOLOGY
Volume 135, Issue 2, Pages 381-390

Publisher

SPRINGER
DOI: 10.1007/s11060-017-2585-7

Keywords

Gliomas; Telomeric markers; Alternative lengthening of telomeres; C-circle assay; ATRX expression

Funding

  1. Fondation de France
  2. Ligue Grand-Ouest contre le Cancer, comites Eure-et-Loir, Ille-et-Vilaine, Indre-et-Loire, Morbihan, Vendee, Vienne (MC lab)
  3. French National Research Agency (ANR: project BIVANDEV)
  4. Ligue contre le Cancer, comites du Puy-de-Dome et Ardeche
  5. Fondation ARC
  6. Conseil regional d'Auvergne (PA lab)
  7. Plan Cancer-INSERM (Gliobiv) (PV lab) [CS14085CS]
  8. Plan Cancer-INSERM (Gliobiv) (PA lab) [CS14085CS Gliobiv]

Ask authors/readers for more resources

Human malignant gliomas exhibit acquisition of either one of two telomere maintenance mechanisms, resulting from either reactivation of telomerase expression or activation of an alternative lengthening of telomeres (ALT) mechanism. In the present study, we analyzed 63 human malignant gliomas for the presence of ALT-specific extrachromosomal circles of telomeric DNA (C-circles) and measured telomerase expression, telomeric DNA content (Telo/Alu method), and telomeric repeat-containing RNAs (TERRA) levels. We also assessed histomolecular markers routinely used in clinical practice. The presence of C-circles significantly correlated with IDH1/2 mutation, MGMT exon 1 methylation, low Ki-67 immunostaining, increased telomeric DNA content, absence of functional ATRX protein and level of HTERT gene expression. In multivariate analysis, we observed a trend to a correlation between elevated TERRA levels and increased survival. Interestingly, the C-circles assay allowed to detect ALT activation in glioblastomas exhibiting wild-type IDH1/2 and ATRX expression. These results suggest that, after the correlations uncovered here have been confirmed on larger numbers of tumors, telomeric markers might be useful in improving diagnosis. They also point out to the utility of using the specific, sensitive and quantitative C-circle and Telo/Alu assays that can work with as few as 30 ng of tumor DNA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available